Empagliflozin; Linagliptin; Metformin Hydrochloride Patents

Given below is the list of patents protecting Empagliflozin; Linagliptin; Metformin Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.

A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Empagliflozin; Linagliptin; Metformin Hydrochloride's patents.